Advertisement

Month: February 2019

January 2019 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Methotrexate Well Tolerated, Effective for Psoriasis in Chinese […]

Read More

January 2019 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AHA: Nearly Half of U.S. Adults […]

Read More

January 2019 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rising Temps May Up Burden of Congenital […]

Read More

January 2019 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Liver Transplant Wait List May Not Prioritize High-Risk […]

Read More

January 2019 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Report IDs Areas Lacking Good Practice […]

Read More

January 2019 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Oral Antibiotics Noninferior to IV for Bone, […]

Read More

January 2019 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AHA: Nearly Half of U.S. Adults Have Cardiovascular […]

Read More

January 2019 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AHA: Nearly Half of U.S. Adults Have Cardiovascular […]

Read More

January 2019 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Long-Term Incidence of A-Fib Increased […]

Read More

January 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Long-Term Incidence of A-Fib Increased in […]

Read More

January 2019 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Prophylaxis for Gonococcal Eye Infections in Newborns Advised […]

Read More

January 2019 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Oral Antibiotics Noninferior to IV for Bone, Joint […]

Read More

January 2019 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rising Temps May Up Burden of Congenital Heart […]

Read More

January 2019 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. E-Cigarettes More Effective for Smoking Cessation THURSDAY, Jan. […]

Read More

January 2019 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA Approves First Generic Version of Advair for […]

Read More

January 2019 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Methotrexate Well Tolerated, Effective for Psoriasis in Chinese […]

Read More

January 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Liver Transplant Wait List May Not Prioritize High-Risk […]

Read More

January 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Finasteride Not Tied to Increase in Prostate Cancer […]

Read More

January 2019 Briefing – Internal Medicine

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA Approves First Generic Version of Advair […]

Read More

January 2019 Briefing – Critical Care

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Infective Endocarditis Related to Injection Drug Use […]

Read More

For latest news and updates
Email-id is invalid